503 related articles for article (PubMed ID: 26001635)
1. Are patient-reported outcome instruments for ankylosing spondylitis fit for purpose for the axial spondyloarthritis patient? A qualitative and psychometric analysis.
van Tubergen A; Black PM; Coteur G
Rheumatology (Oxford); 2015 Oct; 54(10):1842-51. PubMed ID: 26001635
[TBL] [Abstract][Full Text] [Related]
2. Discriminant validity, responsiveness and reliability of the arthritis-specific Work Productivity Survey assessing workplace and household productivity within and outside the home in patients with axial spondyloarthritis, including nonradiographic axial spondyloarthritis and ankylosing spondylitis.
Osterhaus JT; Purcaru O
Arthritis Res Ther; 2014 Aug; 16(4):R164. PubMed ID: 25099160
[TBL] [Abstract][Full Text] [Related]
3. Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA.
van der Heijde D; Dougados M; Landewé R; Sieper J; Maksymowych WP; Rudwaleit M; Van den Bosch F; Braun J; Mease PJ; Kivitz AJ; Walsh J; Davies O; Bauer L; Hoepken B; Peterson L; Deodhar A
Rheumatology (Oxford); 2017 Sep; 56(9):1498-1509. PubMed ID: 28498975
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Ankylosing Spondylitis Quality of Life assessment tool in patients with non-radiographic axial spondyloarthritis.
Hoepken B; Serrano D; Harris K; Hwang MC; Reveille J
Qual Life Res; 2021 Mar; 30(3):945-954. PubMed ID: 33128725
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study.
Landewé R; Braun J; Deodhar A; Dougados M; Maksymowych WP; Mease PJ; Reveille JD; Rudwaleit M; van der Heijde D; Stach C; Hoepken B; Fichtner A; Coteur G; de Longueville M; Sieper J
Ann Rheum Dis; 2014 Jan; 73(1):39-47. PubMed ID: 24013647
[TBL] [Abstract][Full Text] [Related]
6. The validity and reliability of quality of life questionnaires in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and meta-analysis.
He Q; Luo J; Chen J; Yang J; Yao C; Xu C; Tao Q
Health Qual Life Outcomes; 2022 Jul; 20(1):116. PubMed ID: 35907948
[TBL] [Abstract][Full Text] [Related]
7. Test-retest reliability of outcome measures: data from three trials in radiographic and non-radiographic axial spondyloarthritis.
Boel A; Navarro-Compán V; van der Heijde D
RMD Open; 2021 Dec; 7(3):. PubMed ID: 34893536
[TBL] [Abstract][Full Text] [Related]
8. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
Kilic E; Kilic G; Akgul O; Ozgocmen S
Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
[TBL] [Abstract][Full Text] [Related]
9. Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?
Kiltz U; Baraliakos X; Karakostas P; Igelmann M; Kalthoff L; Klink C; Krause D; Schmitz-Bortz E; Flörecke M; Bollow M; Braun J
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1415-22. PubMed ID: 22505331
[TBL] [Abstract][Full Text] [Related]
10. Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore.
Kwan YH; Tan JJ; Phang JK; Fong W; Lim KK; Koh HL; Lui NL; Tan CS; Østbye T; Thumboo J; Leung YY
Int J Rheum Dis; 2019 Dec; 22(12):2206-2212. PubMed ID: 31721427
[TBL] [Abstract][Full Text] [Related]
11. Validity and reliability of the ten-item Connor-Davidson Resilience Scale (CD-RISC10) instrument in patients with axial spondyloarthritis (axSpA) in Singapore.
Kwan YH; Ng A; Lim KK; Fong W; Phang JK; Chew EH; Lui NL; Tan CS; Thumboo J; Østbye T; Leung YY
Rheumatol Int; 2019 Jan; 39(1):105-110. PubMed ID: 30523476
[TBL] [Abstract][Full Text] [Related]
12. Impact of Certolizumab Pegol on Patient-Reported Outcomes in Patients With Axial Spondyloarthritis.
Sieper J; Kivitz A; van Tubergen A; Deodhar A; Coteur G; Woltering F; Landewé R
Arthritis Care Res (Hoboken); 2015 Oct; 67(10):1475-80. PubMed ID: 25832312
[TBL] [Abstract][Full Text] [Related]
13. Validation and reliability of translation of the ASAS Health Index in a Colombian Spanish-speaking population with spondyloarthritis.
Bautista-Molano W; Landewé RBM; Kiltz U; Valle-Oñate R; van der Heijde D
Clin Rheumatol; 2018 Nov; 37(11):3063-3068. PubMed ID: 30259248
[TBL] [Abstract][Full Text] [Related]
14. Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients--baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice.
Wallman JK; Kapetanovic MC; Petersson IF; Geborek P; Kristensen LE
Arthritis Res Ther; 2015 Dec; 17():378. PubMed ID: 26703005
[TBL] [Abstract][Full Text] [Related]
15. Activity Limitations in Patients with Axial Spondyloarthritis: A Role for Fear of Movement and (Re)injury Beliefs.
Swinnen TW; Vlaeyen JWS; Dankaerts W; Westhovens R; de Vlam K
J Rheumatol; 2018 Mar; 45(3):357-366. PubMed ID: 29142031
[TBL] [Abstract][Full Text] [Related]
16. Clinical performance of ASAS Health Index in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: real-world evidence from Multicenter Nationwide Registry.
Akgul O; Bodur H; Ataman S; Yurdakul FG; Capkin E; Gurer G; Sezer I; Duruoz MT; Melikoglu MA; Cay HF; Rezvani A; Yagci I; Gogus F; Kamanli A; Cevik R
Rheumatol Int; 2020 Nov; 40(11):1793-1801. PubMed ID: 32814986
[TBL] [Abstract][Full Text] [Related]
17. Relationship between disease activity status or clinical response and patient-reported outcomes in patients with non-radiographic axial spondyloarthritis: 104-week results from the randomized controlled EMBARK study.
Dougados M; van der Heijde D; Tsai WC; Saaibi D; Marshall L; Jones H; Pedersen R; Vlahos B; Tarallo M
Health Qual Life Outcomes; 2020 Jan; 18(1):4. PubMed ID: 31900174
[TBL] [Abstract][Full Text] [Related]
18. Certolizumab pegol for treating axial spondyloarthritis.
Desmarais J; Beier S; Deodhar A
Expert Opin Biol Ther; 2016 Aug; 16(8):1059-64. PubMed ID: 27366922
[TBL] [Abstract][Full Text] [Related]
19. Tumor Necrosis Factor-α Inhibition in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Treatment Response, Drug Survival, and Patient Outcome.
Corli J; Flipo RM; Philippe P; Bera-Louville A; Béhal H; Wibaux C; Paccou J
J Rheumatol; 2015 Dec; 42(12):2376-82. PubMed ID: 26568593
[TBL] [Abstract][Full Text] [Related]
20. General practitioners' perceptions of their ability to identify and refer patients with suspected axial spondyloarthritis: a qualitative study.
van Onna M; Gorter S; van Meerendonk A; van Tubergen A
J Rheumatol; 2014 May; 41(5):897-901. PubMed ID: 24692524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
